Oxford Biomedica Solutions
Zach Window is a Quality Assurance Specialist at the Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA since September 2023. Previously, Zach held the position of QC LIMS Administrator at Oxford Biomedica Solutions from November 2022 to September 2023. Prior experience includes working as an Analytical Development Associate III at Arranta Bio from May 2021 to October 2022, a Senior Quality Control Analyst in Microbiology at Homology Medicines, Inc. from August 2019 to May 2021, and various roles at Boston Analytical from December 2016 to August 2019, culminating as Microbiologist III. Zach earned a Bachelor’s Degree in Biological Sciences from UNH Manchester between 2013 and 2016.
This person is not in any offices
Oxford Biomedica Solutions
Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), and Homology Medicines, Inc. (Nasdaq: FIXX) (“Homology”). We offer global pharmaceutical and biotechnology clients innovative manufacturing expertise in AAV and lentiviral-based cell and gene therapies. Oxford Biomedica Solutions LLC provides access to Homology’s innovative and proven end-to-end AAV manufacturing capabilities, and customers also benefit from technical synergies brought in by the Group’s know-how in lentiviral vector manufacturing. This collaborative and complementary vector-based approach has the potential to accelerate our collective mission to improve patients’ lives worldwide.